Navigation Links
Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
Date:11/20/2007

EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. ("NTI") (Nasdaq: NTII) today announced that it was notified on November 19, 2007 by The NASDAQ Stock Market that it has regained compliance with applicable NASDAQ Capital Market continued listing standards. Previously, the NASDAQ Listing Qualifications Department had notified NTI that it was not in compliance with the $35 million market value of listed securities continued listing requirement. NTI regained compliance following the closing on November 2, 2007 of its underwritten stock offering, in which it raised gross proceeds of $60 million and net proceeds of approximately $55 million through the offering and sale of 21,818,181 shares of common stock.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Neurobiological Technologies Reports Going Concern Qualification
2. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
3. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
4. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
5. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
6. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
7. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
8. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
9. Advanced technologies aim to transform the coaching of top athletes
10. Global Med Technologies(R) Extends Its Worldwide Outreach
11. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)...eading dermatology company serves growing professi... Palo Alto, CA (PRWEB) August 28, 2008...tal firm, today announced that together with Musta...eading a Series A round of financing for Profex.In...invested $15.5 million in the round. Profex, a lea...
(Date:8/28/2008)... not injury itself, associated with increased plaq...) -- A group of researchers has described hourly c...o play a key role in Alzheimer,s disease. , In... was directly linked to brain cell communication i... cell communication increased, so did amyloid beta...
(Date:8/28/2008)...he Accreditation Council for Continuing Medical Ed... of the College of American Pathologists (CAP) the...ovider of continuing medical education for physici...WEB) August 28, 2008 -- The Accreditation Council ...ed the Education Division of the www.cap.org [Co...
(Date:8/28/2008)...eading personal injury law firm files notice of cl...ice Department. , Mineola...andersfirm.com/attorney.asp?attorneyid=14 [Marc G...nal injury law firm of Sanders, Sanders, Block, Wo...rk, today announced that his firm has filed a Noti...
Breaking Medicine News(10 mins):Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2
...nstructors at a Florida Boot Camp beat a black tee...act were captured// by a surveillance camera. Ini...as a natural death, but upon a second postmortem, ...Martin Anderson all of 14, had been brutally beate...
...cle in the January 2006 issue of AGD Impact, the n...GD), says that braces are the best way to correct ...ry,// which deals with crooked teeth is a great he..., and health of an individual’s teeth." “Orthodon...
...y was conducted which showed the level of awarenes...er eight out of ten women using the Progestogen-on...in three hours of the normal time of intake. Due...ing pregnant. The survey was conducted among more ...
...re is an answer, not to far, to the complexities o...according to researchers at the University of Calg...y have developed a way of growing pancreatic cells... of Dr. Leo Behie, “This is a significant mileston...
Other Medicine News:
(Date:8/27/2008)... Memorial Hospital one of 18 centers involved in 1...wire/ -- Results of a 10-year study,published in t...edicine,found that magnesium sulfate administered ...educed the risk of cerebral palsy by 50 percent. T...te (BEAM) trial was,conducted in 18 centers in the...
(Date:8/27/2008)...rance, August 27 /-, - Ora...ults in a,Pharmacodynamic Study Conducted in an Al...nces the highly positive results of a new study,co...The study on Oralair(R) Grasses included 86 adult ...fferent treatment durations: 1 week, 1 month,2 an...
(Date:8/26/2008)...e., Aug. 26 /- The Oregon Tourism Com...Customer Service Training Program,(Q Care) this we...e is a training program created to support the tou...loyee education. By emphasizing,the importance of ...employees with tools and resources to better serve...
(Date:8/26/2008)...LIS, Aug. 26 /- Semafore Pharmaceutic...al Congress on Targeted Therapies,in Cancer in Was...ulti-targeted kinase inhibitors that demonstrate s...ies., A novel and proprietary molecular scaffold ...lowing for the design of pan-PI3 kinase inhibitors...
Breaking Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3OncoGenex reports lead drug candidate OGX 011 achieved primary endpoint in Phase 2 Trial with second line chemotherapy for prostate cancer 3335 1OncoGenex reports lead drug candidate OGX 011 achieved primary endpoint in Phase 2 Trial with second line chemotherapy for prostate cancer 3335 2OncoGenex reports lead drug candidate OGX 011 achieved primary endpoint in Phase 2 Trial with second line chemotherapy for prostate cancer 3335 3OncoGenex reports lead drug candidate OGX 011 achieved primary endpoint in Phase 2 Trial with second line chemotherapy for prostate cancer 3335 4Hcareers com Strengthens Local Market Candidate Reach Through RegionalHelpWanted com Acquisition 3333 1Hcareers com Strengthens Local Market Candidate Reach Through RegionalHelpWanted com Acquisition 3333 2Poniard Pharmaceuticals Announces Positive First line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 1377 1Poniard Pharmaceuticals Announces Positive First line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 1377 2Poniard Pharmaceuticals Announces Positive First line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 1377 3Poniard Pharmaceuticals Announces Positive First line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 1377 4Poniard Pharmaceuticals Announces Positive First line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 1377 5Learning Takes Center Stage at My Urban Toddler 12019 1Learning Takes Center Stage at My Urban Toddler 12019 2
... Proprietary EX.P.R.T. Release Technology essent...,, No stent shortening,, Unique anatom...e carotid bifurcation,, 0.014 Rapid Exchang...ible atraumatic tip,, Radiopaque marker on ...
From top to bottom, EZ STEER Bi-Directional Catheters put amazing responsiveness, predictability, and comfort close at hand. Utilizing a patented Biosense Webster micro-tensioning system that enables
... STaK-Chex, a whole blood assayed hematology contr... white cell differential available with the Coulte...s 14-day open-vial stability, 105-day closed-vial ... levels. The 4.0ml pierceable cap vial is compatib...
The Pilot® thoracolumbar pedicle screw system has been engineered to deliver implants safely and quickly while maximizing versatility. Whether instrumenting through an open procedure or through
Medicine Products: